Endocrinology Practice Questions

Q: Intracellular receptors are present for which of the following substances?

All of the above. **Explanation:** The mechanism of hormone action is determined by the chemical nature of the hormone. Hormones that are **lipid-soluble (lipophilic)** can easily diffuse through the lipid bilayer of the cell membrane to bind with **intracellular receptors**, whereas water-soluble hormones bind to cell surface receptors. 1. **Estrogen:** As a steroid hormone derived from cholesterol, it is lipophilic. It binds to intracellular receptors (specifically **Type I nuclear receptors**) in the cytoplasm or nucleus, which then act as transcription factors to alter gene expression. 2. **Vitamin D:** Although often classified as a vitamin, it functions as a steroid hormone (Calcitriol). It binds to the **Vitamin D Receptor (VDR)**, a nuclear receptor, to regulate calcium homeostasis. 3. **Thyroxine (T4/T3):** Despite being derived from the amino acid tyrosine, thyroid hormones are unique because they are lipophilic. They enter the cell via carrier-mediated transport and bind to **Type II nuclear receptors** already located on the DNA. Since all three substances utilize intracellular/nuclear receptors to exert their physiological effects, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Cytoplasmic Receptors:** Primarily used by Glucocorticoids and Mineralocorticoids. * **Nuclear Receptors:** Primarily used by Estrogen, Progesterone, Testosterone, Thyroid hormones (T3/T4), and Retinoic acid. * **Mnemonic for Intracellular Receptors:** **"PET TV"** (Progesterone, Estrogen, Testosterone, Thyroid hormones, Vitamin D/A). * **Speed of Action:** Hormones acting via intracellular receptors have a **slow onset** (hours to days) but **long duration** of action because they require new protein synthesis.

Q: Within the endocrine system, specificity of communication is determined by what?

The presence of specific receptors on target cells. ### Explanation **1. Why the Correct Answer is Right:** In the endocrine system, hormones are secreted into the bloodstream and distributed throughout the entire body. Despite being exposed to numerous tissues, a hormone only elicits a response in specific **target cells**. This specificity is governed by the presence of **specific receptors** (proteins) that have a high affinity for that particular hormone. If a cell lacks the receptor, it remains "blind" to the hormone's signal, regardless of the hormone's concentration. This is the fundamental principle of ligand-receptor interaction in endocrinology. **2. Why the Other Options are Wrong:** * **Option A:** While the chemical nature (water-soluble vs. lipid-soluble) determines how a hormone travels in the blood and where its receptor is located (surface vs. intracellular), it does not determine which specific cell responds. * **Option B:** Unlike paracrine signaling, endocrine communication is independent of distance; hormones are designed to act on distant organs via the circulatory system. * **Option C:** This describes the **nervous system**, where specificity is determined by precise **anatomical "hard-wiring"** (synapses). In contrast, the endocrine system is "wireless" and relies on molecular recognition. **3. NEET-PG High-Yield Pearls:** * **Up-regulation vs. Down-regulation:** Target cells can modulate their sensitivity by changing the number of receptors (e.g., insulin resistance involves down-regulation of receptors). * **Receptor Locations:** * **Cell Surface:** For peptides (Insulin, GH) and catecholamines. * **Cytoplasmic:** For Steroids (Glucocorticoids). * **Nuclear:** For Thyroid hormones (T3/T4) and Retinoic acid. * **Spare Receptors:** Often, a maximal biological response is achieved when only a small fraction of receptors are occupied (e.g., LH receptors in Leydig cells).

Q: What is the primary role of calcitonin in calcium regulation?

To lower serum calcium levels. **Explanation:** **Calcitonin** is a peptide hormone secreted by the **parafollicular cells (C-cells)** of the thyroid gland. Its primary physiological role is to act as a "calcium-lowering" hormone, serving as a physiological antagonist to Parathyroid Hormone (PTH). **Why Option A is correct:** Calcitonin lowers serum calcium levels primarily through two mechanisms: 1. **Bone:** It directly inhibits **osteoclast** activity, thereby reducing bone resorption and the release of calcium into the blood. 2. **Kidneys:** It increases the urinary excretion of calcium by inhibiting renal tubular reabsorption. **Why the other options are incorrect:** * **Option B:** Increasing serum calcium is the primary function of **Parathyroid Hormone (PTH)** and **Vitamin D (Calcitriol)**. * **Options C & D:** While calcitonin does promote phosphaturia (decreasing serum phosphate), its **primary** and most significant regulatory role is defined by its effect on calcium homeostasis. PTH also decreases phosphate levels, but it is the dominant regulator of phosphate balance compared to calcitonin. **NEET-PG High-Yield Pearls:** * **Marker for Medullary Thyroid Carcinoma (MTC):** Calcitonin serves as a specific tumor marker for the diagnosis and post-operative monitoring of MTC. * **The "Escape" Phenomenon:** The hypocalcemic effect of calcitonin is short-lived because osteoclasts eventually become desensitized to it (downregulation of receptors). * **Therapeutic Use:** Due to its ability to inhibit osteoclasts, exogenous calcitonin is used clinically in the treatment of **Paget’s disease**, severe hypercalcemia, and postmenopausal osteoporosis. * **Stimulus:** The primary stimulus for calcitonin secretion is an increase in plasma calcium concentration.

Q: Which of the following statements regarding growth hormone is incorrect?

It lowers blood sugar levels if present in excess.. **Explanation:** **1. Why Option A is the correct (incorrect statement):** Growth Hormone (GH) is a **diabetogenic hormone**. It does not lower blood sugar; instead, it increases it. GH antagonizes the action of insulin, decreases glucose uptake by peripheral tissues (like muscle and adipose tissue), and increases hepatic glucose production (gluconeogenesis). Chronic excess of GH, as seen in acromegaly, can lead to "pituitary diabetes." **2. Analysis of other options:** * **Option B:** GH is strongly **anabolic**. It promotes amino acid uptake and protein synthesis in muscles and organs, leading to a positive nitrogen balance. * **Option C:** In healthy individuals, dopamine stimulates GH release. However, in patients with GH-secreting **pituitary adenomas** (Acromegaly), dopaminergic agonists (like Bromocriptine or Cabergoline) paradoxically **suppress** GH secretion. This is a classic high-yield physiological shift used in medical management. * **Option D:** While GH has some direct effects (like lipolysis), most of its growth-promoting actions (skeletal and cartilage growth) are mediated by **IGF-1 (Somatomedin C)**, which is primarily produced in the liver. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolic effects:** GH is Lipolytic (increases FFA), Diabetogenic (hyperglycemic), and Anabolic (protein sparer). * **Stimulators of GH:** Hypoglycemia, fasting, sleep (Stage 3 & 4), exercise, and Arginine. * **Inhibitors of GH:** Hyperglycemia, Somatostatin, and IGF-1 (via negative feedback). * **Diagnosis:** The gold standard for diagnosing Acromegaly is the failure to suppress GH levels below 1 ng/mL following an **Oral Glucose Tolerance Test (OGTT)**.

Q: C-peptide is secreted by which type of pancreatic islet cell?

Beta cells. **Explanation:** **Why Beta cells are correct:** C-peptide (Connecting peptide) is a byproduct of insulin synthesis within the **Beta cells** of the Islets of Langerhans. Insulin is initially synthesized as a precursor molecule called **Preproinsulin**, which is cleaved into **Proinsulin**. In the Golgi apparatus, proinsulin is packaged into secretory granules where it is cleaved by endopeptidases into equal amounts (equimolar concentrations) of **Insulin** and **C-peptide**. Both are then released into the portal circulation via exocytosis. **Why other options are incorrect:** * **Alpha cells:** These cells secrete **Glucagon**, which increases blood glucose levels by stimulating glycogenolysis and gluconeogenesis. * **Delta cells:** These cells secrete **Somatostatin**, which acts as a universal inhibitor, suppressing the release of both insulin and glucagon. * **F cells (PP cells):** These cells secrete **Pancreatic Polypeptide**, which helps regulate pancreatic exocrine secretions and gallbladder contraction. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnostic Utility:** Since C-peptide is secreted in a **1:1 ratio** with endogenous insulin but has a longer half-life (~30 mins vs. ~5 mins for insulin), it serves as a reliable marker of endogenous Beta-cell function. * **Factitious Hypoglycemia:** In cases of exogenous insulin overdose, C-peptide levels will be **low** (because commercial insulin lacks C-peptide). In contrast, in an **Insulinoma**, both insulin and C-peptide levels will be **elevated**. * **Metabolism:** Unlike insulin, which is primarily cleared by the liver, C-peptide is mainly cleared by the **kidneys**.

Q: Which of the following suppresses the activity of osteoblasts?

Corticosterone. **Explanation:** The correct answer is **Corticosterone** (a glucocorticoid). Glucocorticoids are potent inhibitors of bone formation. They suppress osteoblast activity through several mechanisms: they decrease the proliferation and differentiation of osteoblast precursors, increase the apoptosis of mature osteoblasts and osteocytes, and shift the differentiation of mesenchymal stem cells away from the osteoblast lineage toward adipocytes. **Analysis of Options:** * **A. Vitamin D3 (Calcitriol):** It primarily promotes bone mineralization by increasing intestinal calcium and phosphate absorption. It also stimulates osteoblasts to secrete proteins like osteocalcin and RANKL (which indirectly activates osteoclasts), but its net physiological role is essential for healthy bone formation. * **B. T3 and T4 (Thyroid Hormones):** These are essential for normal bone growth and skeletal maturation. They stimulate osteoblast activity and protein synthesis. While hyperthyroidism can lead to increased bone turnover, thyroid hormones do not "suppress" osteoblasts. * **D. Parathormone (PTH):** PTH has a dual effect. While continuous high levels stimulate osteoclasts (via RANKL from osteoblasts), intermittent low doses of PTH are actually **anabolic** to bone and stimulate osteoblast activity (the basis for the drug Teriparatide). **Clinical Pearls for NEET-PG:** * **Glucocorticoid-Induced Osteoporosis (GIOP):** This is the most common cause of secondary osteoporosis. The hallmark is a decrease in bone formation rather than just an increase in resorption. * **Osteoblast Markers:** High-yield markers for osteoblast activity include **Alkaline Phosphatase (ALP)** and **Osteocalcin**. * **RANKL/OPG Ratio:** Osteoblasts regulate osteoclasts by secreting RANKL (stimulates osteoclasts) and Osteoprotegerin (OPG, inhibits osteoclasts). Glucocorticoids increase RANKL and decrease OPG, further damaging bone integrity.

Question 1

Intracellular receptors are present for which of the following substances?

Accepted Answer

All of the above

Answer

Estrogen

Answer

Vitamin D

Answer

Thyroxine

Question 2

Within the endocrine system, specificity of communication is determined by what?

Accepted Answer

The presence of specific receptors on target cells

Answer

The chemical nature of the hormone

Answer

The distance between the endocrine cell and its target cell(s)

Answer

Anatomical connections between the endocrine and target cells

Question 3

What is the primary role of calcitonin in calcium regulation?

Accepted Answer

To lower serum calcium levels

Answer

To increase serum calcium levels

Answer

To decrease serum phosphate levels

Answer

To increase serum phosphate levels

Question 4

Which of the following is NOT a consequence of primary hyperaldosteronism?

Accepted Answer

Hyperkalemia

Answer

Hypernatremia

Answer

Hydrogen depletion and metabolic alkalosis

Answer

Hypertension

Question 5

When glucose concentration in blood increases, there is a linear increase in which of the following hormones?

Accepted Answer

Insulin

Answer

Glucagon

Answer

Growth Hormone

Answer

Cortisol

Question 6

In a male newborn, adrenogenital syndrome (congenital hyperplasia of the adrenal glands) is most often associated with which of the following?

Accepted Answer

Persistent paramesonephros (Mullerian ducts)

Answer

Normal appearing genitalia

Answer

Hypoglycemia

Answer

Pseudohermaphroditism

Question 7

Which of the following statements regarding growth hormone is incorrect?

Accepted Answer

It lowers blood sugar levels if present in excess.

Answer

It has a strong anabolic action.

Answer

Dopaminergic agonists depress its release in pituitary adenomas.

Answer

Its action is mediated by IGF-1.

Question 8

C-peptide is secreted by which type of pancreatic islet cell?

Accepted Answer

Beta cells

Answer

Alpha cells

Answer

Delta cells

Answer

F cells

Question 9

Which of the following conditions increases aldosterone secretion without affecting glucocorticoid secretion?

Accepted Answer

All of the above

Answer

High potassium intake

Answer

Low sodium intake

Answer

Constriction of the inferior vena cava in the thorax

Question 10

Which of the following suppresses the activity of osteoblasts?

Accepted Answer

Corticosterone

Answer

Vitamin D3

Answer

T3 and T4

Answer

Parathormone

Endocrinology — MCQs

Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?